Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Polatuzumab Vedotin

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Polivy

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Polivy

    Polatuzumab Vedotin

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : Polivy

    Switzerland
    arrow
    Health 2.0 Conference
    Not Confirmed

    Roche

    Polatuzumab Vedotin

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 188

    2019 Revenue in Millions : 57

    Growth (%) : 231

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Polivy

    Polatuzumab Vedotin

    arrow
    IPhEB Russia
    Not Confirmed

    Brand Name : Polivy

    Switzerland
    arrow
    IPhEB Russia
    Not Confirmed

    Roche

    Polatuzumab Vedotin

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 266

    2020 Revenue in Millions : 179

    Growth (%) : 46

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Polivy

    Polatuzumab Vedotin

    arrow
    IPhEB Russia
    Not Confirmed

    Brand Name : Polivy

    Switzerland
    arrow
    IPhEB Russia
    Not Confirmed

    Roche

    Polatuzumab Vedotin

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 478

    2021 Revenue in Millions : 266

    Growth (%) : 80

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Polivy

    Polatuzumab Vedotin

    arrow
    IPhEB Russia
    Not Confirmed

    Brand Name : Polivy

    Switzerland
    arrow
    IPhEB Russia
    Not Confirmed

    Roche

    Polatuzumab Vedotin

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 971

    2022 Revenue in Millions : 478

    Growth (%) : 92

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Polivy

    Polatuzumab Vedotin

    arrow
    IPhEB Russia
    Not Confirmed

    Brand Name : Polivy

    Switzerland
    arrow
    IPhEB Russia
    Not Confirmed

    Roche

    Polatuzumab Vedotin

    Main Therapeutic Indication : Hematology

    Currency : USD

    2024 Revenue in Millions : 1,235

    2023 Revenue in Millions : 971

    Growth (%) : 27

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.